News

  • Cycling may lower dementia risk, study finds

    Cycling instead of driving or taking public transport is linked to a 19 per cent lower risk of developing dementia. An analysis of nearly 480,000 people in Great Britain also found regular cyclists had a 22 per cent lower risk of Alzheimer’s disease compared with those using cars, buses or trains. More than 55m people [...]

  • Exercise may lower dementia risk, study suggests

    Vigorous physical activity lowers levels of a blood protein tied to dementia risk and brain inflammation, new research has found. Almost 1.1m people are predicted to have dementia by 2065 – a 2.5-fold increase. Scientists at the University of Tasmania’s Wicking Dementia Research and Education Centre reported that exercise reduces levels of GFAP (glial fibrillary [...]

  • Chronic insomnia doubles dementia risk, study finds

    Chronic insomnia may accelerate brain ageing by three years and raises dementia risk by 40 per cent, according to new research. The study tracked 2,750 cognitively healthy older adults with an average age of 70 for more than five and a half years. Those with the sleep disorder were far more likely to develop cognitive [...]

  • Pill could prevent dementia and reverse brain age by 10 years

    A new pill being tested could halt dementia progression and reverse the brain’s biological age by a decade, according to its developers. The treatment, called RTR242, works by reviving the brain’s natural cleaning system to clear harmful protein clumps that build up with age. Such clumps are linked to Alzheimer’s, Parkinson’s and Lewy body dementia. [...]

  • Cannabis use quadruples diabetes risk, study finds

    Adults who use cannabis are nearly four times more likely to develop type 2 diabetes than non-users, a major study has found. The research analysed about 96,800 people with cannabis-related diagnoses – from casual use to dependency – and compared them with more than 4.16m individuals who had no record of drug use or chronic [...]

  • NHS dementia staff say patients missing out on best care as diagnosis system falls short

    Nearly a quarter of NHS dementia service staff say they cannot provide patients with the best care, while fewer than a third believe diagnostic processes work. Workers are “being let down by a system that isn’t keeping pace with the scale of the challenge”, says a new survey raising concerns about dementia services across the [...]

  • Jumping could be key to healthy ageing, study finds

    Jumping may help protect ageing bones and cut fracture risks, with research showing short daily routines can strengthen bone density in adults. High-impact exercise strengthens bones, which weaken as the body’s rate of bone formation slows with age. Regular jumping can raise bone density – the level of calcium and other minerals that indicates bone [...]

  • Funding boost for first potentially regenerative treatment for MS

    An international team has secured around £500k to advance a therapy that could halt multiple sclerosis progression, repair nerve damage and potentially restore lost functions. The treatment targets excitotoxicity – a destructive process that kills nerve cells in MS. By blocking this without disrupting normal brain activity, the compound promotes repair of myelin, the protective [...]

  • Round up: First AI-powered app for longevity and more

    Age Tech World explores the latest developments in the world of ageing and longevity. First AI-Powered personalised mobile app for brain health and longevity Digital health company Tolion Health has announced the beta release of its flagship product, the Tolion Brain Coach mobile application. This beta release offers early access to Tolion AI Engine, designed [...]

  • Half of people stop taking weight-loss drug within a year, study finds

    Half of adults without diabetes who begin taking the weight-loss drug semaglutide stop within a year, according to a Danish population-wide study. The research tracked 77,310 first-time users in Denmark between December 2022 and October 2023. More than half (40,262; median age 50 years, 72 per cent women) had discontinued after 12 months. At three, [...]